| The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: a concise review L Rossi, A McCartney, I De Santo, E Risi, E Moretti, L Malorni, L Biganzoli, ... Cancer Treatment Reviews 74, 29-34, 2019 | 27 | 2019 |
| Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled … L Rossi, C Biagioni, A McCartney, I Migliaccio, G Curigliano, G Sanna, ... Breast Cancer Research 21, 1-7, 2019 | 19 | 2019 |
| The modern landscape of endocrine therapy for premenopausal women with breast cancer L Rossi, O Pagani Breast Care 10 (5), 312-315, 2015 | 17 | 2015 |
| Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women L Rossi, O Pagani Current treatment options in oncology 18, 1-10, 2017 | 15 | 2017 |
| Matrix-producing carcinoma of the breast: a case report L Rossi, C Paglicci, G Caprio, S Barberi, E Ranieri, S Zancla, M Rengo, ... Case Reports in Oncology 6 (2), 245-249, 2013 | 15 | 2013 |
| Can we make a portrait of women with inoperable locally advanced breast cancer? G Montagna, AR Schneeberger, L Rossi, GB Micheli, F Meani, M Imperiali, ... The Breast 33, 83-90, 2017 | 12 | 2017 |
| The role of gonadotropin-releasing-hormone analogues in the treatment of breast cancer L Rossi, O Pagani Journal of Women's Health 27 (4), 466-475, 2018 | 10 | 2018 |
| An unusual orbital metastasis of breast cancer L Rossi, S Zancla, L Civitelli, E Ranieri Breast Disease 34 (4), 173-176, 2014 | 9 | 2014 |
| Platinum-based agent and fluorouracil in metastatic breast cancer: a retrospective monocentric study with a review of the literature L Rossi, C Biagioni, A McCartney, E Moretti, M Pestrin, G Sanna, E Risi, ... Anticancer Research 38 (8), 4839-4845, 2018 | 8 | 2018 |
| Impact of breast cancer treatment on fertility L Rossi, O Pagani Breast cancer, fertility preservation and reproduction, 29-43, 2015 | 7 | 2015 |
| Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence? L Rossi, A McCartney, E Risi, L Malorni, L Biganzoli, A Di Leo Therapeutic advances in medical oncology 10, 1758835918815591, 2018 | 6 | 2018 |
| The impact of depression on adherence to organized and opportunistic breast cancer screening in Switzerland G Montagna, AR Schneeberger, L Rossi, H Reina, F Schwab, ... The Breast 44, S44-S45, 2019 | 4 | 2019 |
| A rare avascolar osteonecrosis of the knee related to biphosphonate treatment in a patient with metastatic breast cancer L Rossi, SD Lascio, M Kouros, O Pagani Breast Disease 35 (3), 203-206, 2015 | 3 | 2015 |
| The open issues regarding cyclin-dependent kinase 4/6 inhibitors in the management of advanced breast cancer L Yang, Y Cai, D Zhang, J Sun, C Xu, W Zhao, W Jiang, C Pan, L Rossi Journal of Breast Cancer 21 (4), 468-470, 2018 | 2 | 2018 |
| Expression of urokinase plasminogen activator (uPA) in the leukocytes and tissues of patients with benign and malignant breast lesions S Barberi, G Montagna, L Rossi Breast disease 38 (1), 15-23, 2019 | 1 | 2019 |
| Young breast cancer survivors and insomnia: a multicenter Swiss snapshot L Rossi, G Montagna, O Pagani, W Weber, U Güth, K Zaman, M Rabaglio, ... The Breast 41, S27, 2018 | | 2018 |
| The management of young women with breast cancer in Switzerland: a snapshot G Montagna, L Rossi, O Pagani, D Terribile, F Meani, A Bordoni, E Rapiti The Breast 41, S24, 2018 | | 2018 |
| Die gegenwärtige Landschaft der endokrinen Therapie für prämenopausale Frauen mit Brustkrebs: Übersetzung aus Breast Care 2015; 10: 312-315 (DOI: 10.1159/000439462) L Rossi, O Pagani Kompass Onkologie 3 (1), 14-18, 2016 | | 2016 |
| Too young for breast cancer? A dangerous prejudice L Rossi, G Montagna, O Pagani EUROPEAN JOURNAL OF CANCER 57, S86-S86, 2016 | | 2016 |
